Early vs. Late Androgen Suppression Therapy for Advanced Prostate Cancer
نویسندگان
چکیده
منابع مشابه
Intermittent Androgen Suppression Therapy for Prostate Cancer Patients: An Update
Prostate cancer is the leading cause of cancer and the second leading cause of cancer-related deaths among men in the Western world [1]. For early stage prostate cancer treatment with surgery and radiation is often curative; however, about 10–20% of men with prostate cancer present with metastatic disease at diagnosis, while 20–30% of patients diagnosed with local‐ ized disease will eventually ...
متن کاملCost-effectiveness of androgen suppression therapies in advanced prostate cancer.
BACKGROUND The costs and side effects of several antiandrogen therapies for advanced prostate cancer differ substantially. We estimated the cost-effectiveness of antiandrogen therapies for advanced prostate cancer. METHODS We performed a cost-effectiveness analysis using a Markov model based on a formal meta-analysis and literature review. The base case was assumed to be a 65-year-old man wit...
متن کاملLifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study.
BACKGROUND Healthy lifestyle behaviors could have a role in ameliorating some of the adverse effects of androgen suppression therapy (AST) in men with prostate cancer. The primary aim of this study was to assess the feasibility of a tapered supervised exercise program in combination with dietary advice in men with advanced prostate cancer receiving AST. METHODS Advanced prostate cancer patien...
متن کاملAutophagy in Prostate Cancer and Androgen Suppression Therapy
The role of autophagy is known to be highly complex and context-dependent, leading to both cancer suppression and progression in several tumors including melanoma, breast and prostate cancer. In the present review, recent advances in an understanding of the involvement of autophagy in prostate cancer treatment are described. The regulatory effects of androgens on prostate cancer cell autophagy ...
متن کاملIntermittent versus continuous androgen deprivation therapy in advanced prostate cancer.
Intermittent androgen deprivation is increasingly employed as an alternative to continuous life long androgen deprivation therapy for men with advanced or recurrent prostate cancer. Two recent phase III trials have clarified the benefits of intermittent therapy. In men with non-metastatic disease with PSA recurrence after definitive local therapy, intermittent therapy showed equivalent survival...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: AJN, American Journal of Nursing
سال: 2021
ISSN: 0002-936X
DOI: 10.1097/01.naj.0000731644.35094.db